Marina Marchetti Selected Research

Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells

12/2019

Rituximab for treatment of autoimmune acquired platelet function disorders: description of two cases of acquired Glanzmann thrombasthenia and one case of acquired delta storage pool disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marina Marchetti Research Topics

Disease

20	Neoplasms (Cancer) 11/2021 - 08/2003
13	Thrombosis (Thrombus) 01/2022 - 01/2003
9	Breast Neoplasms (Breast Cancer) 04/2021 - 01/2008
9	Essential Thrombocythemia 01/2014 - 05/2007
6	Hemorrhage 01/2022 - 01/2003
6	Polycythemia Vera 07/2013 - 11/2008
3	COVID-19 01/2022 - 01/2021
3	Thrombophilia 01/2022 - 10/2007
3	Inflammation (Inflammations) 07/2021 - 02/2006
2	Thrombasthenia (Glanzmann Thrombasthenia) 01/2022 - 12/2019
2	Venous Thromboembolism 08/2017 - 05/2010
2	Leukemia 11/2012 - 02/2011
2	Activated Protein C Resistance (APC Resistance) 01/2012 - 11/2008
1	Hemophilia A (Haemophilia) 12/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 04/2021
1	Drug-Related Side Effects and Adverse Reactions 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Virus Diseases (Viral Diseases) 01/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021
1	Thrombotic Thrombocytopenic Purpura 01/2020
1	Lymphatic Metastasis 01/2020
1	Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells 12/2019
1	Shock 01/2018
1	Familial Breast Cancer 09/2015
1	Lymphoma (Lymphomas) 11/2012
1	Multiple Myeloma 11/2012
1	Factor VII Deficiency (Hypoproconvertinemia) 08/2012
1	Lung Neoplasms (Lung Cancer) 02/2011
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 05/2010
1	Leukocytosis (Pleocytosis) 01/2008
1	Myeloproliferative Disorders (Myeloproliferative Disorder) 01/2008
1	Hemostatic Disorders 11/2003
1	Neoplasm Metastasis (Metastasis) 11/2003

Drug/Important Bio-Agent (IBA)

13	Hemostatics (Antihemorrhagics)IBA 01/2022 - 11/2003
11	Thrombin FDA Link 01/2021 - 11/2008
10	Biomarkers (Surrogate Marker)IBA 01/2022 - 05/2010
4	Heparin (Liquaemin)FDA LinkGeneric 01/2021 - 10/2007
4	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 08/2017 - 10/2007
3	fibrin fragment D (D-dimer)IBA 01/2022 - 08/2017
3	AnticoagulantsIBA 08/2017 - 10/2006
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 10/2011 - 01/2003
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2018
2	Pharmaceutical PreparationsIBA 01/2022 - 12/2021
2	Fibrinogen (Factor I)FDA Link 01/2022 - 01/2020
2	Biological ProductsIBA 01/2022 - 10/2009
2	EnzymesIBA 04/2021 - 08/2012
2	AntibodiesIBA 01/2021 - 01/2020
2	Rituximab (Mabthera)FDA Link 01/2021 - 12/2019
2	Thromboplastin (Tissue Factor)IBA 08/2012 - 07/2009
2	Conditioned Culture MediaIBA 02/2011 - 01/2008
2	Dalteparin (Dalteparin Sodium)FDA Link 01/2008 - 02/2006
1	Factor XIII (Coagulation Factor XIII)IBA 01/2022
1	Surface Antigens (Surface Antigen)IBA 01/2022
1	IntegrinsIBA 01/2022
1	Plasminogen Activator Inhibitor 1IBA 01/2022
1	AutoantibodiesIBA 01/2022
1	CollagenIBA 01/2022
1	COVID-19 VaccinesIBA 12/2021
1	Hormones (Hormone)IBA 04/2021
1	Tissue Plasminogen Activator (Alteplase)FDA Link 04/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Antiviral Agents (Antivirals)IBA 01/2021
1	SolutionsIBA 01/2021
1	Phenobarbital (Luminal)FDA Link 01/2020
1	Prothrombin (Factor II)IBA 01/2020
1	AntithrombinsIBA 01/2020
1	Blood Coagulation Factors (Coagulation Factor)IBA 01/2020
1	Protamines (Protamine Sulfate)FDA Link 01/2018
1	Nonsense Codon (Nonsense Mutation)IBA 09/2015
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2014
1	Purinergic P2 Receptors (ADP Receptor)IBA 07/2013
1	Adenosine Diphosphate (ADP)IBA 07/2013
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 07/2013
1	Immunomodulating AgentsIBA 11/2012
1	SteroidsIBA 11/2012
1	CoagulantsIBA 08/2012
1	Peptide Hydrolases (Proteases)FDA Link 08/2012
1	Factor XII (Hageman Factor)IBA 08/2012
1	Serine Proteases (Serine Protease)IBA 08/2012
1	Hydroxyurea (Hydrea)FDA LinkGeneric 09/2011
1	Vitamin K FDA Link 07/2011
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 05/2011
1	bemiparinIBA 02/2011
1	SelectinsIBA 07/2010
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2010
1	P-SelectinIBA 05/2010
1	von Willebrand FactorIBA 07/2009
1	Annexin A5IBA 07/2009
1	Protein CIBA 11/2008
1	CytokinesIBA 01/2008
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2008
1	Enoxaparin (Lovenox)FDA LinkGeneric 01/2008
1	FibrinIBA 11/2003

Therapy/Procedure

7	Therapeutics 01/2021 - 08/2003
6	Drug Therapy (Chemotherapy) 01/2021 - 05/2010
1	Plasmapheresis 01/2021
1	Adjuvant Chemotherapy 01/2020
1	Remission Induction 05/2010